Shares of Autolus Therapeutics were up more than 12% this morning after the company announced it forged an exclusive licensing agreement with Moderna to develop new messenger RNA therapeutics for cancer.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,